AKT1 and benign prostatic hyperplasia: Although Xu et al. [15] reported anti-prostate cancer effects of paeonol through modulating apoptosis via capspase-dependent and PI3K/Akt pathways in DU145 cell lines, its efficacy in BPH remains unexplored to the best of our knowledge.